Does Dapagliflozin Cause UTI? Symptoms, Risks & Prevention

Quick Answer Yes, dapagliflozin can increase urinary tract infection (UTI) risk by 5-7% compared to placebo. The medication causes glucose to be expelled through urine, creating an environment where bacteria can thrive. Most UTIs are mild and treatable, but proper hygiene and hydration can significantly reduce risk. 📚 Main Guide: Complete Dapagliflozin Information Table of Contents Why Dapagliflozin Increases UTI Risk UTI Symptoms to Watch For Who Is at Higher Risk? 7 Ways to Prevent UTIs on Dapagliflozin When to Call Your Doctor Treatment Options Introduction Dapagliflozin (brand name Farxiga) is a highly effective SGLT2 inhibitor used to treat type 2 diabetes, heart failure, and chronic kidney disease. While it offers significant benefits in blood sugar control and cardiovascular protection, one of the most commonly reported side effects is an increased risk of urinary tract infections. Clinical trials show that approximately 5-7% of patients taking dapagliflozin develop UTIs, compared to 3-4% taking placebo. This represents a modest but real increase that patients should understand and prepare for. The good news? Most UTIs associated with dapagliflozin are mild, easily treatable with antibiotics, and can often be prevented with proper hygiene practices. Understanding why dapagliflozin increases UTI risk, recognizing symptoms early, and implementing preventive strategies can help you safely benefit from this medication while minimizing complications. Why Dapagliflozin Increases UTI Risk Dapagliflozin works by blocking SGLT2 receptors in the kidneys, which normally reabsorb glucose from urine back into the bloodstream. When these receptors are blocked, excess glucose is eliminated through urine instead of being retained in the body. The Glucose-Bacteria Connection This mechanism creates a glucose-rich environment in the urinary tract, which can promote bacterial growth. Bacteria, particularly E. coli (responsible for 80-90% of UTIs), thrive in sugar-rich environments. The higher glucose concentration in urine provides an ideal breeding ground for these organisms. Key Point: The same mechanism that helps lower blood sugar (glucose excretion in urine) also creates conditions favorable for bacterial growth in the urinary tract. Additional Contributing Factors Increased urination: Dapagliflozin causes osmotic diuresis (more urine production), which can lead to incomplete bladder emptying Genital moisture: More frequent urination can increase genital moisture, creating conditions for bacterial growth Immune factors: People with diabetes often have slightly compromised immune function, making infections more likely UTI Symptoms to Watch For Recognizing UTI symptoms early allows for prompt treatment and prevents complications. Common symptoms include: Lower Urinary Tract Infection (Cystitis) Frequent urge to urinate – feeling like you need to go often, even when little urine comes out Burning sensation – pain or burning feeling during urination Cloudy or strong-smelling urine – urine may appear murky or have an unusual odor Pelvic discomfort – pressure or pain in the lower abdomen or pelvic area Blood in urine – pink or red-tinged urine (hematuria) Upper Urinary Tract Infection (Pyelonephritis) These symptoms require immediate medical attention: Fever above 101°F (38.3°C) Chills and shaking Back or flank pain (kidney area) Nausea and vomiting Confusion or altered mental state (especially in elderly) Warning: If you develop fever, severe back pain, or confusion along with urinary symptoms, seek immediate medical care. These may indicate a kidney infection. Who Is at Higher Risk? While anyone taking dapagliflozin can develop a UTI, certain factors increase risk: Gender Women are at significantly higher risk than men due to shorter urethral length, which allows bacteria easier access to the bladder. Studies show UTI rates of 7-9% in women vs. 1-2% in men taking dapagliflozin. Age Postmenopausal women: Decreased estrogen affects urinar